Results 161 to 170 of about 96,485 (242)

PASI Focuses on Advanced Neural Prostheses [PDF]

MRS Bulletin, 2009
openaire   +1 more source

Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study. [PDF]

Dermatol Ther (Heidelb)
Torres T, Sood S, Yilmaz O, Vender RB, Prajapati VH, Puig L, Megna M, Marzano AV, Gisondi P, Carrascosa JM, Dauden E, Llamas-Velasco M, Balato A, Leal BG, Prignano F, Bellinato F, Silvi G, Di Brizzi EV, Potestio L, Carrera CG, López-Ferrer A, Del-Alcazar E, Mufti A, Maul LV, Piaserico S, Maul JT, Yeung J.   +26 more
europepmc   +1 more source

PASI pre-test analysis results

A report on pretest analyses using codes of partners choice PASI basic data and PASI test plans as input specified test configurations parameters boundary conditions but no knowledge of actual test results ...
openaire   +1 more source

Clinical proof of concept for small molecule mediated inhibition of IL-17 in psoriasis. [PDF]

PLoS One
Warren RB, Hunter HJA, Papp KA, Gordon KB, Tang MT, Enejosa JV, Huang KC, Raha D, Batugedara HM, Skinner C, Kobel PA, Rademacher PM, Ghilardi N, Fatheree P, Jacobsen JR, Lu TT.   +15 more
europepmc   +1 more source

Incremental Cost per Responder (PASI-75, PASI-90 and PASI-100) Based on a Network Meta-Analysis of Biologic Therapies for Psoriasis: Spain 2018

Actas Dermo-Sifiliográficas (English Edition), 2019
openaire   +2 more sources

Real-World Effectiveness of Brodalumab in Challenging Psoriasis Subgroups: Insights from the PSO-TARGET Cohort. [PDF]

Dermatol Ther (Heidelb)
Reguiai Z, Ghislain PD, Baudier E, Zraik A, Boyé T.   +4 more
europepmc   +1 more source

Real-world experience with deucravacitinib in psoriatic patients: the Chilean perspective. [PDF]

An Bras Dermatol
Valenzuela Ahumada F, Contreras Aguilera J, Alcayaga de la Ribera F, Cabrera Moraga R, Lecaros Cornejo C.   +4 more
europepmc   +1 more source

Evaluation of chemerin levels in the pathogenesis of psoriasis. [PDF]

Front Med (Lausanne)
Matwiejuk M, Kulczyńska-Przybik A, Łukaszuk B, Myśliwiec H, Myśliwiec P, Chabowski A, Mroczko B, Flisiak I.   +7 more
europepmc   +1 more source

Anti-Psoriatic Effects of J2H-1802, a Mycophenolate Mofetil and 5-Aminosalicylic Acid Hybrid, in an Imiquimod-Induced Psoriasis-like Mouse Model. [PDF]

Pharmaceutics
Park SH, Lee JH, Yoon KN, Yang G, Kim J, Lee JY, Choi K, Jung K, Lee S, Son WC, Kang KS.   +10 more
europepmc   +1 more source